PAX8 and renal cell carcinoma: if both renal cell carcinoma and lung adenocarcinoma are in the differential diagnosis based on morphology and/or clinical history a broad IHC panel including TTF-1, PAX-8 and vimentin should be applied for a definitive diagnosis.